「no」の検索結果
164件：31～35件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
e 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical Co., Ltd, Hyogo, Japan. 2: Baylor Coll...
http://www.senju.co.jp/english/rd/thesis/ -
General Announcement: September 6, 2024 Senju Pharmaceutical Co., Ltd. Launch of Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
suring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeApproval（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Reti...
http://www.senju.co.jp/english/rd/pipeline.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
http://www.senju.co.jp/english/rd/ -
Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical
suing this new avenue of opportunity, Senju Pharmaceutical has entered the promising field of otorhinolaryngological drugs.
https://www.senju.co.jp/english/about/business/mp.html